Drug exposure of first‐line anti‐tuberculosis drugs in China: A prospective pharmacological cohort study

Aim Exploring the need for optimization of drug exposure to improve tuberculosis (TB) treatment outcome is of great importance. We aimed to describe drug exposure at steady state as well as the population pharmacokinetics (PK) of rifampicin (RIF), isoniazid (INH) and pyrazinamide (PZA) in Chinese TB...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	British journal of clinical pharmacology 2021-03, Vol.87 (3), p.1347-1358
Hauptverfasser:	Gao, Yazhou, Davies Forsman, Lina, Ren, Weihua, Zheng, Xubin, Bao, Ziwei, Hu, Yi, Bruchfeld, Judith, Alffenaar, Jan‐Willem
Format:	Artikel
Sprache:	eng
Schlagworte:	antituberculosis drugs dosing strategy drug exposure Medicin och hälsovetenskap population pharmacokinetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!